Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SCAMP: Stepped Care for Depression and Pain
NCT00118430Phase 4Completed
- Sponsor
- Indiana University
- Start
- Sep 2004
- Primary completion
- Jul 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of venlafaxine, duloxetine, fluoxetine, sertraline, citalopram and 2 more in major depressive disorder (MDD) and Musculoskeletal pain (3 arms), sponsored by Indiana University. Primary endpoints: Brief Pain Inventory Interference at 1 year and Hopkins Symptom Checklist-20 Depression Severity at 1 year. Started Sep 2004; status: completed.
02
Drugs
venlafaxineduloxetinefluoxetinesertralinecitalopram
03
Conditions
major depressive disorder (MDD)Musculoskeletal pain
Beyond the preview
Go deeper on NCT00118430.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00118430.